{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:11:04Z","timestamp":1793373064400,"version":"4.5.0"},"reference-count":210,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.drudis.2025.104364","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:16:01Z","timestamp":1745500561000},"page":"104364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities"],"prefix":"10.1016","volume":"30","author":[{"given":"Nadine","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanigaimalai","family":"Pillaiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104364_b0005","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"van den Hoogen","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2025.104364_b0010","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3390\/v13122449","article-title":"Interactions between the nucleoprotein and the phosphoprotein of pneumoviruses: Structural insight for rational design of antivirals","volume":"13","author":"Decool","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0015","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1099\/jgv.0.000959","article-title":"ICTV virus taxonomy profile: pneumoviridae","volume":"98","author":"Rima","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3201\/eid1004.030393","article-title":"Antigenic and genetic variability of human metapneumoviruses","volume":"10","author":"van den Hoogen","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3201\/eid1201.050772","article-title":"Novel human metapneumovirus sublineage","volume":"12","author":"Huck","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0030","doi-asserted-by":"crossref","first-page":"27730","DOI":"10.1038\/srep27730","article-title":"Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes","volume":"6","author":"Chow","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jmv.21081","article-title":"Molecular epidemiology of human metapneumovirus in Ireland","volume":"80","author":"Carr","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0040","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3201\/eid1006.031097","article-title":"Global genetic diversity of human metapneumovirus fusion gene","volume":"10","author":"Boivin","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0042-6822(03)00528-2","article-title":"Genetic diversity between human metapneumovirus subgroups","volume":"315","author":"Biacchesi","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0050","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/jmv.24249","article-title":"Clinical features of human metapneumovirus genotypes in children with acute lower respiratory tract infection in Changsha, China","volume":"87","author":"Zeng","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jinf.2023.05.004","article-title":"The emergence, impact, and evolution of human metapneumovirus variants from 2014 to 2021 in Spain","volume":"87","author":"Pinana","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.drudis.2025.104364_b0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmoldx.2011.09.004","article-title":"Genotype variability and clinical features of human metapneumovirus isolated from Korean children, 2007 to 2010","volume":"14","author":"Kim","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.drudis.2025.104364_b0065","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jmv.21242","article-title":"Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections in five epidemic seasons in Stockholm, Sweden, 2002-2006","volume":"80","author":"Rafiefard","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jmv.24024","article-title":"Human metapneumovirus prevalence and molecular epidemiology in respiratory outbreaks in Ontario, Canada","volume":"87","author":"Neemuchwala","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00365540802227110","article-title":"Human metapneumovirus pneumonia in children: results of an Italian study and mini-review","volume":"40","author":"Don","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0080","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/CMR.00015-11","article-title":"Human Metapneumovirus: lessons learned over the first decade","volume":"24","author":"Schildgen","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.drudis.2025.104364_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijid.2014.03.1394","article-title":"Human metapneumovirus: review of an important respiratory pathogen","volume":"25","author":"Panda","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/1348-0421.12543","article-title":"A novel 111-nucleotide duplication in the G gene of human metapneumovirus","volume":"61","author":"Saikusa","year":"2017","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fmicb.2017.00402","article-title":"180-nucleotide duplication in the G gene of human metapneumovirus A2b subgroup strains circulating in Yokohama City, Japan, since 2014","volume":"8","author":"Saikusa","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2025.104364_b0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/fmb-2016-0211","article-title":"Novel human metapneumovirus with a 180-nucleotide duplication in the G gene","volume":"12","author":"Pinana","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.drudis.2025.104364_b0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11033-022-08092-8","article-title":"The emergence of human metapneumovirus G gene duplication in hospitalized patients with respiratory tract infection, India, 2016-2018","volume":"50","author":"Parida","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0110","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.inf.0000108190.09824.e8","article-title":"Clinical impact and diagnosis of human metapneumovirus infection","volume":"23","author":"van den Hoogen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.drudis.2025.104364_b0115","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1086\/379200","article-title":"Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients","volume":"188","author":"van den Hoogen","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00831-21","article-title":"Respiratory pathogen coinfections in SARS-CoV-2-positive patients in Southeastern Wisconsin: a retrospective analysis","volume":"9","author":"Scott","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.drudis.2025.104364_b0125","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2214-109X(20)30393-4","article-title":"Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.drudis.2025.104364_b0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/499274","article-title":"The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience","volume":"193","author":"Williams","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244093","article-title":"Human Metapneumovirus: epidemiology and genotype diversity in children and adult patients with respiratory infection in Cordoba, Argentina","volume":"15","author":"Rodriguez","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104364_b0145","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2927","article-title":"Human metapneumovirus circulation in the United States, 2008 to 2014","volume":"137","author":"Haynes","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.drudis.2025.104364_b0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jmv.24687","article-title":"Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection","volume":"89","author":"Yan","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/519846","article-title":"A summer outbreak of human metapneumovirus infection in a long-term-care facility","volume":"196","author":"Louie","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0160","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1086\/513204","article-title":"An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility","volume":"44","author":"Boivin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/CMR.00081-15","article-title":"Modulation of host immunity by the human metapneumovirus","volume":"29","author":"Cespedes","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.drudis.2025.104364_b0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.12688\/f1000research.12625.1","article-title":"Human metapneumovirus \u2013 what we know now","volume":"7","author":"Shafagati","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.drudis.2025.104364_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/v5010087","article-title":"Human metapneumovirus in adults","volume":"5","author":"Haas","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcv.2011.10.002","article-title":"Ten years of human metapneumovirus research","volume":"53","author":"Feuillet","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2019.05.007","article-title":"Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults","volume":"117","author":"Choi","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0190","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12038-008-0067-y","article-title":"Human metapneumovirus: a new respiratory pathogen","volume":"33","author":"Broor","year":"2008","journal-title":"J Biosci"},{"key":"10.1016\/j.drudis.2025.104364_b0195","series-title":"Fields Virology","first-page":"1449","article-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"2007"},{"key":"10.1016\/j.drudis.2025.104364_b0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12627","article-title":"Nucleocapsid assembly in pneumoviruses is regulated by conformational switching of the N protein","volume":"5","author":"Renner","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2025.104364_b0205","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.1038\/s41598-017-14448-z","article-title":"Structural dissection of human metapneumovirus phosphoprotein using small angle x-ray scattering","volume":"7","author":"Renner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/viro.2001.1355","article-title":"Analysis of the genomic sequence of a human metapneumovirus","volume":"295","author":"van den Hoogen","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0215","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1469-0691.2004.00980.x","article-title":"Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses","volume":"10","author":"Latiff","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.drudis.2025.104364_b0220","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/JVI.75.3.1117-1123.2001","article-title":"Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein","volume":"75","author":"Coronel","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0225","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/jvi.65.3.1057-1065.1991","article-title":"Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids","volume":"65","author":"Kaptur","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1099\/0022-1317-83-4-753","article-title":"Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells","volume":"83","author":"Ghildyal","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1099\/vir.0.19707-0","article-title":"Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues","volume":"85","author":"Rodriguez","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017818","article-title":"The human metapneumovirus matrix protein stimulates the inflammatory immune response in vitro","volume":"6","author":"Bagnaud-Baule","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104364_b0245","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.78.13.6927-6937.2004","article-title":"The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness","volume":"78","author":"Skiadopoulos","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0250","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1128\/JVI.01287-06","article-title":"Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH","volume":"80","author":"Schowalter","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0255","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1128\/JVI.06706-11","article-title":"Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate","volume":"86","author":"Chang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0260","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1128\/JVI.01133-12","article-title":"The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins","volume":"86","author":"Cox","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0265","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0801433106","article-title":"Integrin \u03b1v\u03b21 promotes infection by human metapneumovirus","volume":"106","author":"Cseke","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104364_b0270","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01641-23","article-title":"Novel insights into the host cell glycan binding profile of human metapneumovirus","volume":"98","author":"Van Den Bergh","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0275","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.virol.2005.10.016","article-title":"Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity","volume":"345","author":"Skiadopoulos","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0280","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1023\/A:1010467106305","article-title":"Virus membrane fusion proteins: biological machines that undergo a metamorphosis","volume":"20","author":"Dutch","year":"2000","journal-title":"Biosci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0285","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/382536","article-title":"Human metapneumovirus: a new player among respiratory viruses","volume":"38","author":"Hamelin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0290","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3390\/v4123785","article-title":"Diversity in glycosaminoglycan binding amongst hMPV G protein lineages","volume":"4","author":"Adamson","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0295","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1128\/JVI.01208-08","article-title":"Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection","volume":"82","author":"Thammawat","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0300","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1128\/JVI.79.19.12608-12613.2005","article-title":"Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates","volume":"79","author":"Biacchesi","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0305","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1128\/JVI.78.23.12877-12887.2004","article-title":"Recombinant human Metapneumovirus lacking the small hydrophobic SH and\/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate","volume":"78","author":"Biacchesi","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.962925","article-title":"Role of human metapneumovirus glycoprotein G in modulation of immune responses","volume":"13","author":"Velayutham","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000077","article-title":"Human metapneumovirus glycoprotein G inhibits innate immune responses","volume":"4","author":"Bao","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.drudis.2025.104364_b0320","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1128\/JVI.02584-07","article-title":"Human metapneumovirus small hydrophobic protein inhibits NF-\u03baB transcriptional activity","volume":"82","author":"Bao","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0325","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1128\/JVI.02848-13","article-title":"The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity","volume":"88","author":"Masante","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1993.1561","article-title":"Paramyxovirus fusion: a hypothesis for changes","volume":"197","author":"Lamb","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003309","article-title":"Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein","volume":"9","author":"Krzyzaniak","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.drudis.2025.104364_b0340","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.96.20.11259","article-title":"The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription","volume":"96","author":"Bermingham","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104364_b0345","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/JVI.79.11.6588-6597.2005","article-title":"Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity","volume":"79","author":"Buchholz","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0350","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-019-1759-1","article-title":"Structure of the human metapneumovirus polymerase phosphoprotein complex","volume":"577","author":"Pan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104364_b0355","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/v13050834","article-title":"Structural insights into the respiratory syncytial virus RNA synthesis complexes","volume":"13","author":"Cao","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0360","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1097\/01.inf.0000187274.48387.42","article-title":"Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis","volume":"24","author":"DeVincenzo","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.drudis.2025.104364_b0365","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0370","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0375","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: Recommendations of the advisory committee on immunization practices \u2013 United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0380","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.drudis.2025.104364_b0385","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/pch\/14.8.521","article-title":"Prevention of respiratory syncytial virus infection","volume":"14","author":"Samson","year":"2009","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.drudis.2025.104364_b0390","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.chom.2023.07.002","article-title":"Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode","volume":"31","author":"Wen","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2025.104364_b0395","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41467-023-36459-3","article-title":"Cross-protective antibodies against common endemic respiratory viruses","volume":"14","author":"Caban","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104364_b0400","doi-asserted-by":"crossref","first-page":"16272","DOI":"10.1038\/nmicrobiol.2016.272","article-title":"Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.drudis.2025.104364_b0405","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/biomedicines10102516","article-title":"A candidate therapeutic monoclonal antibody inhibits both HRSV and HMPV replication in mice","volume":"10","author":"Fausther-Bovendo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104364_b0410","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.drudis.2025.104364_b0415","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104364_b0420","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0425","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2023","volume":"72","author":"Melgar","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0430","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0435","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0440","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101337","article-title":"Structural basis for respiratory syncytial virus and human metapneumovirus neutralization","volume":"61","author":"Miller","year":"2023","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0450","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jpids\/pix006","article-title":"Evaluation of a live attenuated human metapneumovirus vaccine in adults and children","volume":"7","author":"Karron","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.drudis.2025.104364_b0455","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1099\/vir.0.83250-0","article-title":"Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus","volume":"88","author":"Hamelin","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0460","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1016\/j.vaccine.2007.10.022","article-title":"Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection","volume":"25","author":"de Swart","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2025.104364_b0465","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/j.vaccine.2007.04.075","article-title":"Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged","volume":"25","author":"Yim","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2025.104364_b0470","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1016\/j.vaccine.2024.04.048","article-title":"VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice","volume":"42","author":"Trinite","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2025.104364_b0475","article-title":"Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus","volume":"19","author":"Ma","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.drudis.2025.104364_b0480","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1016\/j.vaccine.2008.05.052","article-title":"Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques","volume":"26","author":"Herfst","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2025.104364_b0485","article-title":"A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3324\/haematol.2018.206896","article-title":"Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections","volume":"105","author":"Vasileiou","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.drudis.2025.104364_b0495","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.jtct.2023.12.135","article-title":"ALVR106, an off-the-shelf, multivirus-specific T-cell therapy, for the treatment of respiratory viral infections: Results from a Phase 1, First-in-human, dose-ranging trial","volume":"30","author":"Nikiforow","year":"2024","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.drudis.2025.104364_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103579","article-title":"COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease","volume":"28","author":"Kronenberger","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2025.104364_b0505","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acs.jmedchem.1c00335","article-title":"Kinases as potential therapeutic targets for anti-coronaviral therapy","volume":"65","author":"Pillaiyar","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104364_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112275","article-title":"A medicinal chemistry perspective of drug repositioning: recent advances and challenges in drug discovery","volume":"195","author":"Pillaiyar","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104364_b0515","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/med.21724","article-title":"The recent outbreaks of human coronaviruses: a medicinal chemistry perspective","volume":"41","author":"Pillaiyar","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.drudis.2025.104364_b0520","doi-asserted-by":"crossref","first-page":"52471","DOI":"10.1074\/jbc.M308917200","article-title":"Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase","volume":"278","author":"Bougie","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2025.104364_b0525","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/AAC.33.10.1668","article-title":"Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction","volume":"33","author":"Fernandez-Larsson","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0530","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00109-001-0308-0","article-title":"Ribavirin\u2019s antiviral mechanism of action: lethal mutagenesis?","volume":"80","author":"Crotty","year":"2002","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.drudis.2025.104364_b0535","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104364_b0540","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0042-6822(03)00152-1","article-title":"The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA","volume":"310","author":"Zhou","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0545","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986730607220401123801","article-title":"Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents","volume":"6","author":"Franchetti","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2025.104364_b0550","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0555","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-3542(03)00153-0","article-title":"Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro","volume":"60","author":"Wyde","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0560","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/AAC.50.2.774-777.2006","article-title":"Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection","volume":"50","author":"Hamelin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0565","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2014.01.003","article-title":"Paediatric human metapneumovirus infection: epidemiology, prevention and therapy","volume":"59","author":"Principi","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0570","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/23744235.2016.1204661","article-title":"Human metapneumovirus in lung transplant recipients: characteristics and outcomes","volume":"48","author":"Niggli","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.drudis.2025.104364_b0575","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.healun.2007.05.020","article-title":"Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin","volume":"26","author":"Raza","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.drudis.2025.104364_b0580","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/bmt.2008.80","article-title":"Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients","volume":"41","author":"Safdar","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.drudis.2025.104364_b0585","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pbc.23019","article-title":"Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child","volume":"57","author":"Shachor-Meyouhas","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.drudis.2025.104364_b0590","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CVI.00230-15","article-title":"New approaches for immunization and therapy against human metapneumovirus","volume":"22","author":"Wen","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b0595","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0600","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/AAC.00709-16","article-title":"Antiviral activity of favipiravir (T-705) against a broad range of paramyxoviruses in vitro and against human metapneumovirus in hamsters","volume":"60","author":"Jochmans","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0605","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619830197","article-title":"A medium-throughput screen for inhibitors of human metapneumovirus","volume":"27","author":"Becker","year":"2019","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0610","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3892\/ijmm.2014.1761","article-title":"Simvastatin modulates cellular components in influenza A virus-infected cells","volume":"34","author":"Mehrbod","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.drudis.2025.104364_b0615","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s42003-023-04990-0","article-title":"Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerases","volume":"6","author":"Kleiner","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.drudis.2025.104364_b0620","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2005.09.007","article-title":"Paramyxovirus membrane fusion: lessons from the F and HN atomic structures","volume":"344","author":"Lamb","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0625","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/emboj\/20.15.4024","article-title":"Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion","volume":"20","author":"Russell","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2025.104364_b0630","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1128\/JVI.01243-06","article-title":"Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region","volume":"81","author":"Miller","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0635","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104364_b0640","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/viro.1996.0459","article-title":"Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection","volume":"223","author":"Yao","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0645","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-291X(03)00197-9","article-title":"Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion","volume":"302","author":"Wang","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2025.104364_b0650","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104364_b0655","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMra022812","article-title":"Novel therapies based on mechanisms of HIV-1 cell entry","volume":"348","author":"Kilby","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104364_b0660","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2025.104364_b0665","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1745-7254.2005.00193.x","article-title":"HIV entry inhibitors: a new generation of antiretroviral drugs","volume":"26","author":"Krambovitis","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.drudis.2025.104364_b0670","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.00793-07","article-title":"Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus","volume":"52","author":"Deffrasnes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0675","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00425-015-2277-5","article-title":"HRA2pl peptide: a fusion inhibitor for human metapneumovirus produced in tobacco plants by transient transformation","volume":"242","author":"M\u00e1rquez-Escobar","year":"2015","journal-title":"Planta"},{"key":"10.1016\/j.drudis.2025.104364_b0680","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1125135","article-title":"The HRA2pl fusion peptide exerts in vitro antiviral activity against human respiratory paramyxoviruses and pneumoviruses","volume":"13","author":"Meza","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2025.104364_b0685","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2004.02.006","article-title":"Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays","volume":"63","author":"Wyde","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105405","article-title":"Antiviral strategies against human metapneumovirus: targeting the fusion protein","volume":"207","author":"Van Den Bergh","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0695","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1099\/jgv.0.001135","article-title":"Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice","volume":"99","author":"Le","year":"2018","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0700","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bph.14084","article-title":"Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections","volume":"175","author":"Le","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2025.104364_b0705","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/AAC.00771-12","article-title":"Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide","volume":"56","author":"Donalisio","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0710","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.antiviral.2010.01.003","article-title":"Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate","volume":"85","author":"Luganini","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076482","article-title":"Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures","volume":"8","author":"Bon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104364_b0720","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1128\/JVI.01362-16","article-title":"Inhibition of human metapneumovirus binding to heparan sulfate blocks infection in human lung cells and airway tissues","volume":"90","author":"Klimyte","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0725","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1039\/D1CC01593A","article-title":"Platinum complexes act as shielding agents against virus infection","volume":"57","author":"Bailly","year":"2021","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.drudis.2025.104364_b0730","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2014.05.018","article-title":"In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition","volume":"108","author":"Rodriguez","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0735","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/jmv.24457","article-title":"Characterization of in vitro dengue virus resistance to carrageenan","volume":"88","author":"Talarico","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0740","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.antiviral.2011.08.010","article-title":"In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus","volume":"92","author":"Wang","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0745","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1465-9921-14-124","article-title":"Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial","volume":"14","author":"Ludwig","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.drudis.2025.104364_b0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carres.2017.10.020","article-title":"Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds","volume":"453\u2013454","author":"Shi","year":"2017","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.drudis.2025.104364_b0755","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/825203","article-title":"Antiviral potential of algae polysaccharides isolated from marine sources: a review","volume":"2015","author":"Ahmadi","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2025.104364_b0760","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/md9122514","article-title":"Seaweed polysaccharides and derived oligosaccharides stimulate defense responses and protection against pathogens in plants","volume":"9","author":"Vera","year":"2011","journal-title":"Mar Drugs"},{"key":"10.1016\/j.drudis.2025.104364_b0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214646","article-title":"Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus","volume":"14","author":"Ciejka","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104364_b0770","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.02183-15","article-title":"Novel polyanions inhibiting replication of influenza viruses","volume":"60","author":"Ciejka","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199223","article-title":"Identification of gamma-Fagarine as a novel antiviral agent against respiratory virus (hMPV) infection","volume":"336","author":"Li","year":"2023","journal-title":"Virus Res"},{"key":"10.1016\/j.drudis.2025.104364_b0780","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(00)00091-7","article-title":"Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo","volume":"47","author":"Kimura","year":"2000","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0785","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1099\/vir.0.2008\/003301-0","article-title":"Effect of NMSO3 treatment in a murine model of human metapneumovirus infection","volume":"89","author":"Spetch","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0790","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/522609","article-title":"DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection","volume":"196","author":"Belser","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0795","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12879-016-1358-9","article-title":"A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase(R)) in adult subjects with well-controlled asthma","volume":"16","author":"Colombo","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0800","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104364_b0805","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2019.04.001","article-title":"New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase","volume":"167","author":"Chibanga","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0810","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0815","doi-asserted-by":"crossref","first-page":"24138","DOI":"10.1038\/srep24138","article-title":"A dual drug regimen synergistically blocks human parainfluenza virus infection","volume":"6","author":"Bailly","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0820","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/emi.2014.60","article-title":"The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo","volume":"3","author":"Ren","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.drudis.2025.104364_b0825","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1038\/s41598-024-58032-8","article-title":"Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivity","volume":"14","author":"Luck","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0830","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/chromsci\/38.4.169","article-title":"High-performance liquid chromatography-electrospray ionization-mass spectrometry study of ginkgolic acid in the leaves and fruits of the ginkgo tree (Ginkgo biloba)","volume":"38","author":"He","year":"2000","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.drudis.2025.104364_b0835","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jcp.25426","article-title":"Ginkgolic acid inhibits invasion and migration and TGF-\u03b2-induced EMT of lung cancer cells through PI3K\/Akt\/mTOR inactivation","volume":"232","author":"Baek","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2025.104364_b0840","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/v13010086","article-title":"Ginkgolic acid inhibits herpes simplex virus type 1 skin infection and prevents zosteriform spread in mice","volume":"13","author":"Bhutta","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0845","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/ph14100980","article-title":"Ginkgolic acid inhibits coronavirus strain 229E infection of human epithelial lung cells","volume":"14","author":"Bhutta","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2025.104364_b0850","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13578-022-00806-6","article-title":"Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci"},{"key":"10.1016\/j.drudis.2025.104364_b0855","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/v12040449","article-title":"Broad antiviral activity of ginkgolic acid against Chikungunya, Mayaro, Una, and Zika viruses","volume":"12","author":"Campos","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0860","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1038\/s41598-020-61700-0","article-title":"Ginkgolic acid inhibits fusion of enveloped viruses","volume":"10","author":"Borenstein","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0865","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01008-22","article-title":"Drug repurposing for therapeutic discovery against human metapneumovirus infection","volume":"66","author":"Van Den Bergh","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0870","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jac\/dkp502","article-title":"Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid","volume":"65","author":"Hung","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.drudis.2025.104364_b0875","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3389\/fmicb.2019.00718","article-title":"Potent inhibition of Zika virus replication by aurintricarboxylic acid","volume":"10","author":"Park","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2025.104364_b0880","doi-asserted-by":"crossref","first-page":"e8350","DOI":"10.1371\/journal.pone.0008350","article-title":"Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases","volume":"4","author":"Hashem","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104364_b0885","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1152\/ajplegacy.1969.216.3.675","article-title":"Equilibrium and kinetic properties of the Evans blue-albumin system","volume":"216","author":"Freedman","year":"1969","journal-title":"Am J Physiol"},{"key":"10.1016\/j.drudis.2025.104364_b0890","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03681-20","article-title":"Multidisciplinary approaches identify compounds that bind to human ACE2 or SARS-CoV-2 spike protein as candidates to block SARS-CoV-2-ACE2 receptor interactions","volume":"12","author":"Day","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.drudis.2025.104364_b0895","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7628037","article-title":"Evans blue dye: a revisit of its applications in biomedicine","volume":"2018","author":"Yao","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.drudis.2025.104364_b0900","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/viro.2002.1685","article-title":"Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA","volume":"304","author":"Diamond","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b0905","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2014.12.011","article-title":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus","volume":"115","author":"Cheng","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0910","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1099\/vir.0.061911-0","article-title":"Interferon-\u03b2 and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays","volume":"95","author":"Hart","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0915","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1348-0421.12828","article-title":"Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2","volume":"64","author":"Kato","year":"2020","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b0920","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/acs.jmedchem.1c00302","article-title":"Kinase inhibitors as underexplored antiviral agents","volume":"65","author":"Garcia-Carceles","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104364_b0925","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104364_b0930","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/acs.jmedchem.0c01467","article-title":"Recent developments in the use of kinase inhibitors for management of viral infections","volume":"65","author":"Raghuvanshi","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104364_b0935","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1099\/jgv.0.001401","article-title":"Dengue virus non-structural protein 1 activates the p38 MAPK pathway to decrease barrier integrity in primary human endothelial cells","volume":"101","author":"Barbachano-Guerrero","year":"2020","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0940","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2014.08.004","article-title":"Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580","volume":"110","author":"Fu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0945","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.05.007","article-title":"p38 MAPK inhibition: a promising therapeutic approach for COVID-19","volume":"144","author":"Grimes","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.drudis.2025.104364_b0950","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2017.07.012","article-title":"p38MAPK plays a critical role in induction of a pro-inflammatory phenotype of retinal Muller cells following Zika virus infection","volume":"145","author":"Zhu","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.drudis.2025.104364_b0955","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/biomedicines11061516","article-title":"Probenecid, an old drug with potential new uses for central nervous system disorders and neuroinflammation","volume":"11","author":"Garcia-Rodriguez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104364_b0960","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/v14050912","article-title":"Probenecid inhibits respiratory syncytial virus (RSV) replication","volume":"14","author":"Murray","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0965","doi-asserted-by":"crossref","first-page":"18085","DOI":"10.1038\/s41598-021-97658-w","article-title":"Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro","volume":"11","author":"Murray","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104364_b0970","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/v15071508","article-title":"Oral probenecid for nonhospitalized adults with symptomatic mild-to-moderate COVID-19","volume":"15","author":"Martin","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0975","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/v16071087","article-title":"Probenecid inhibits human metapneumovirus (HMPV) replication in vitro and in BALB\/c mice","volume":"16","author":"Bergeron","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104364_b0980","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1165\/rcmb.2005-0287OC","article-title":"Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus","volume":"34","author":"Guerrero-Plata","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.drudis.2025.104364_b0985","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1128\/JVI.79.14.8894-8903.2005","article-title":"Pathogenesis of human metapneumovirus lung infection in BALB\/c mice and cotton rats","volume":"79","author":"Hamelin","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104364_b0990","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-8-6","article-title":"Human metapneumovirus induces more severe disease and stronger innate immune response in BALB\/c mice as compared with respiratory syncytial virus","volume":"8","author":"Huck","year":"2007","journal-title":"Respir Res"},{"key":"10.1016\/j.drudis.2025.104364_b0995","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fimmu.2020.00432","article-title":"Inhibition of PI3K\u03b4 enhances Poly I:C-induced antiviral responses and inhibits replication of human metapneumovirus in murine lungs and human bronchial epithelial cells","volume":"11","author":"Fujita","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b1000","article-title":"Human metapneumovirus SH protein promotes JAK1 degradation to impair host IL-6 signaling","author":"Brynes","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2025.104364_b1005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.virol.2016.04.022","article-title":"Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation","volume":"494","author":"Hastings","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104364_b1010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1099\/vir.0.055632-0","article-title":"Human metapneumovirus inhibits the IL-6-induced JAK\/STAT3 signalling cascade in airway epithelium","volume":"95","author":"Mitzel","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.drudis.2025.104364_b1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024496","article-title":"Human metapneumovirus inhibits IFN-\u03b2 signaling by downregulating Jak1 and Tyk2 cellular levels","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104364_b1020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.563336","article-title":"Human metapneumovirus induces IRF1 via TANK-binding kinase 1 and type I IFN","volume":"12","author":"Loevenich","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104364_b1025","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1484245","article-title":"Fumarprotocetraric acid and geraniin were identified as novel inhibitors of human respiratory syncytial virus infection in vitro","volume":"14","author":"Wang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2025.104364_b1030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.coviro.2012.02.016","article-title":"Henipavirus outbreaks to antivirals: the current status of potential therapeutics","volume":"2","author":"Broder","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.drudis.2025.104364_b1035","doi-asserted-by":"crossref","first-page":"12648","DOI":"10.1021\/jacs.9b04615","article-title":"Dual inhibition of human parainfluenza type 3 and respiratory syncytial virus infectivity with a single agent","volume":"141","author":"Outlaw","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2025.104364_b1040","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1021\/jacs.9b11548","article-title":"Structure-guided improvement of a dual HPIV3\/RSV fusion inhibitor","volume":"142","author":"Outlaw","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2025.104364_b1045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/molecules22071190","article-title":"Antiviral lipopeptide-cell membrane interaction is influenced by PEG linker length","volume":"22","author":"Augusto","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104364_b1050","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msae263","article-title":"MEGA12: molecular evolutionary genetic analysis version 12 for adaptive and green computing","volume":"41","author":"Kumar","year":"2024","journal-title":"Mol Biol Evol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:21:07Z","timestamp":1758126067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":210,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1359644625000777"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104364","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104364"}}